2nd Quarter - Report

ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Period 2nd Quarter 2018 Filed Jul 19, 2018 Signed by Meghan Jackson

Official filing
Firm
ERVIN GRAVES STRATEGY GROUP, LLC
Client
EMERGENT BIOSOLUTIONS INC.
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
JAMES L ERVIN Chairman & CEO
MEGHAN JACKSON —
COLBY MILLER —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE

Budget/Appropriations BUD

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
JAMES L ERVIN Chairman & CEO
MEGHAN JACKSON —
COLBY MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS)

Homeland Security HOM

FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense

LobbyistCovered position, as disclosed
JAMES L ERVIN Chairman & CEO
MEGHAN JACKSON —
COLBY MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.